Mapping proton therapy dose and radiation quality to reduce side effects

Dose Linear Energy Transfer Volume Histogram and Dosimetric Seed Spot Analysis in Spot Scanning Proton Therapy

NIH-funded research Mayo Clinic Arizona · NIH-11146356

This work creates clear 3D maps of proton dose and radiation quality to help people getting brain or head-and-neck proton therapy have safer treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Arizona NIH-funded
Lab location1 site (Scottsdale, United States)
Project IDNIH-11146356 on NIH RePORTER

What this research studies

They will combine each patient's planned radiation dose and linear energy transfer (LET) into a single 3D surface called a dose-LET volume histogram (DLVH) to show where high-energy deposits occur. The team will link those maps to follow-up CT, MRI, and PET images and to reported adverse events to find small 'seed spots' that seem to cause injuries like brain necrosis or bone damage. From those findings they will propose organ-level dose-LET constraints (DLVCs) that treatment planners can use to avoid risky hotspots. The work uses real patient treatment plans and imaging and focuses on people treated with spot-scanning proton therapy.

Who could benefit from this research

Good fit: Ideal participants are people receiving or who have received spot-scanning proton therapy for brain or head-and-neck tumors whose treatment plans and follow-up imaging can be shared.

Not a fit: Patients not treated with proton therapy, those with conditions unrelated to radiation exposure, or those unable to provide images or treatment records are unlikely to benefit directly.

Why it matters

Potential benefit: If successful, this could lower rates of serious side effects from proton therapy by guiding planners to avoid high-risk dose and LET hotspots.

How similar studies have performed: Prior research has suggested links between LET and tissue injury, but combining dose and LET into a DLVH and linking seed-spot findings to clinical harms is a relatively new approach.

Where this research is happening

Scottsdale, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.